IPCA Laboratories Limited

Ipca Laboratories Ltd is a leading Indian pharmaceutical company engaged in the manufacture and marketing of formulations and active pharmaceutical ingredients (APIs) on a global scale. Founded in 1949 and headquartered in Mumbai, Ipca operates a vertically integrated business model with a wide presence across over 120 countries, providing therapies in areas such as pain management, cardiovascular, anti-malarial, anti-diabetic, and anti-infectives. The company is well recognized for its capabilities in process chemistry, backward integration, and compliance with international quality standards, with manufacturing sites approved by major global health authorities, including US FDA, UK MHRA, and WHO-GMP.

Ipca’s product portfolio encompasses both branded and generic formulations, serving institutional customers, hospitals, governments, and retail chemists. Its global footprint is complemented by substantial R&D and manufacturing infrastructure, supported by over 13,000 employees. In addition to its generic business, Ipca is among the largest suppliers of anti-malarial drugs worldwide, holding significant market shares in both India and key international markets such as Sub-Saharan Africa.